AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment.

Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.

GSK has struck a voluntary agreement with the US government to lower the cost of prescription medicines, and expand access to ...

Drugmaker GSK has struck an agreement with the US to cut the cost of prescription medicines for American patients, including ...

Investing.com -- GSK plc (LON:GSK) has entered into an agreement with the U.S. government to reduce prescription medicine costs for American patients, particularly for its respiratory portfolio that ...

Trump on Friday announced what the White House described as the largest set of developments to date under his administration’s push to bring prescription drug prices in the United States in line with ...

In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary ...